SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CEPH
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
998 24 0 CEPH
Emcee:  Stephanie Mocilan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
398 ISIP...now your talking real biotech's with potential. Long on ISIP and loIN_GOD_I_TRUST-6/18/1997
397 TD: You can find address for BC at ISIP response #702. Date was in the articlJoe Wesley-6/18/1997
396 hi. could you please tell me the address of biocentury. also, where did you fiThe Dermatologist-6/18/1997
395 Efficacy is key to approval not just safety.harkenman-6/13/1997
394 To ceph followers: June 9, 97 BioCentury report has a column on page A3 about Joe Wesley-6/13/1997
393 While your point regarding risk to others is not incorrect, it does not fit theNeuroInvestment-6/8/1997
392 Dear Neuro, I disagree with your contention that narcolepsy is "not a lifeJonathan Rothschild-6/8/1997
391 Modafinil's NDA has an excellent chance of approval..eventually. Since it iNeuroInvestment-6/8/1997
390 I think it is the time for FDA to schedule the advisary meetting for modafinJeffers Hughes-6/6/1997
389 When is CEPH going to finish this phase I study ? Wednesday October 9 8:03 AJeffers Hughes-6/6/1997
388 Sell your shares with a discount broker and buy it when it tanks. CEPH does haharkenman-6/5/1997
387 Thanks for the quick response. You make excellent points. When a biotech holdBoyce Burge-6/5/1997
386 1) CEPH has two small molecule neurotrophin mimetic/stimulant programs:one is tNeuroInvestment-6/5/1997
385 I have some opinions in this sector. I only own 50 shares CEPH so I can be objeBoyce Burge-6/5/1997
384 I am long on CYTO (years that is is). My price target exceeds 4x multiples, tiharkenman-6/4/1997
383 CYTO is a hot still relatively undiscovered prospect with no current analyst coRocketman-6/4/1997
382 What is your price target for CYTO? In your view, how soon will it get there? DIVYA DUTTA-6/4/1997
381 Already have IOM, in and out of OO as you know and doing well! I am out now buIN_GOD_I_TRUST-6/3/1997
380 On the long side I like NXCO. On the short side AVNT. MarkHedge-6/3/1997
379 Give it up. Deceiving the advisory board hurt CEPH minuscule chance of approvaharkenman-6/2/1997
378 Lull is driving price a little lower ... Steve PS - ...and this board has no aIN_GOD_I_TRUST-6/2/1997
377 Agreed ... SteveIN_GOD_I_TRUST-5/29/1997
376 I'll agree on the cocky part of it. It certainly was, and their egos were Rocketman-5/29/1997
375 Steve, I would call this a stalemate for now......if we look at it as a boneheaWeirdPro Randy-5/28/1997
374 But when would be the stock be at its greater value, right on approval or two mIN_GOD_I_TRUST-5/28/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News